Journal policiesScope of the Journal
Peer review process
SCOPE OF THE JOURNAL
The primary aim of Interactive CardioVascular and Thoracic Surgery is to provide a medium for the publication of high-quality original scientific reports documenting progress in cardiac and thoracic surgery. The journal publishes reports of significant clinical and experimental advances related to surgery of the heart, the great vessels and the chest. Interactive CardioVascular and Thoracic Surgery is an international journal and accepts submissions from all regions.
For details on manuscript preparation and submission please see here .
Authors should observe high standards with respect to publication ethics as set out by the Commission on Publication Ethics (COPE) and International Committee of Medical Journal Editors (ICMJE) . Falsification or fabrication of data, plagiarism, including duplicate publication of the authors’ own work without proper citation, and misappropriation of the work are all unacceptable practices. Any cases of ethical misconduct are treated very seriously and will be dealt with in accordance with the COPE guidelines.
All authors listed on the manuscript should have contributed significantly to the experimental design, its implementation, or analysis and interpretation of the data. All authors should have been involved in the writing of the manuscript at draft and any revision stages, and have read and approved the final version. Anyone who made major contributions to the writing of the manuscript should be listed as an author (e.g. “ghost writing” is prohibited by the Journal) provided that the number of authors remains within the limit set by the journal (please see manuscript preparation instructions for details). Any other individuals who made less substantive contributions to the experiment or the writing of the manuscript should be listed in the acknowledgement section. Any change in authorship (including author order) after the initial manuscript submission must be approved in writing by all authors.
Authorship and 'Umbrella' groups
Many large collaborative studies are organized under a group name which represents all the participants. All articles must have at least one named individual as author. Authors who wish to acknowledge the umbrella group from which the data originate should first list the author(s) of the article and follow this with 'on behalf of the GROUP NAME'. If necessary the names of the participants may be listed in the Acknowledgements section.
By submitting your manuscript to the journal it is understood that this it is an original manuscript and is unpublished work and is not under consideration elsewhere. Plagiarism, including duplicate publication of the author’s own work, in whole or in part without proper citation is not tolerated by the journal. Manuscripts submitted to the journal may be checked for originality using anti-plagiarism software.
Conflicts of interest
At the point of submission, each author should reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated – including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition. When considering whether you should declare a conflicting interest or connection please consider the conflict of interest test: Is there any arrangement that would embarrass you or any of your co-authors if it was to emerge after publication and you had not declared it?
As part of the online submission process, corresponding authors are required to confirm whether they or their co-authors have any conflicts of interest to declare, and in the case of an existing conflict of interest that this is fully declared.
Authors should also include a Conflict of Interest statement in their manuscript as outlined in the manuscript preparation instructions .
If the manuscript is published, Conflict of Interest information, including if none was declared, will be communicated in a statement in the published paper.
When reporting animal experiments authors should indicate whether the institution’s, national research council’s, or any other law on the care and use of laboratory animals was followed.
When reporting on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the Helsinki Declaration (1964, amended most recently in 2008) of the World Medical Association. Manuscripts should include a statement that the patient’s written consent was obtained and any information, including illustrations, should be as anonymized as far as possible. Authors should indicate that the design of the work has been approved by local ethical committees or that it conforms to standards currently applied in the country of origin. The name of the authorizing body should be stated in the paper.
PEER REVIEW PROCESS
All submissions to the journal are initially reviewed by the Editor and his Associates. At this stage manuscripts may be rejected without peer review if it is felt that they are not of high enough priority or not relevant to the journal. This fast rejection process means that authors are given a quick decision and do not need to wait for the review process.
Manuscripts that are not instantly rejected are sent out for peer review, usually to two independent reviewers. Based on the feedback from these reviewers and the Editors’ judgment a decision is given on the manuscript.
Manuscripts may also be sent out for statistical review.
The average time from submission to first decision is 40 days.
Occasionally the journal will issue press releases for some of its articles. Authors submitting to the journal are expected to respect any press embargos set for their manuscript.
For information about this journal's policy, please visit our Author Self-Archiving policy page .
The mention of trade names, commercial products or organizations, and the inclusion of advertisements in Interactive CardioVascular and Thoracic Surgery does not imply endorsement by the Society, the editors, the editorial board, Oxford University Press or the organization to which the authors are affiliated. The editors and publishers have taken all reasonable precautions to verify drug names and doses, the results of experimental work and clinical findings published in Interactive CardioVascular and Thoracic Surgery . The ultimate responsibility for the use and dosage of drugs mentioned in Interactive CardioVascular and Thoracic Surgery and in the interpretation of published material lies with the medical practitioner, and the editors and publishers cannot accept liability for damages arising from any errors or omissions in Interactive CardioVascular and Thoracic Surgery . Please inform the editors of any errors.
The opinions expressed in Interactive CardioVascular and Thoracic Surgery are those of the authors and contributors, and do not necessarily reflect those of the Society the editors, the editorial board, Oxford University Press or the organization to which the authors are affiliated.